VNDA vs ZION · rev $102.2M vs P/E 11, rev $354.0M
Vanda Pharmaceuticals Inc (VNDA) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
VNDA currently screens at market cap $358.4M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the VNDA and ZION stock pages for the full models.
Not investment advice.